NCBiotech News

Lighthouse Lab Services, a medical laboratory consulting, staffing and recruiting company based in Holly Springs, has finalized a merger with Elite Diagnostics, a healthcare consulting and management firm in Charlotte.

Clinical research organization Aperio Clinical Outcomes is the newest tenant in downtown Durham’s progressive American Tobacco Campus.

FUJIFILM Diosynth Biotechnologies U.S.A. has broken ground on a $54 million, 31,778-square-foot expansion of its biomanufacturing facilities in Morrisville.

Alcami Corp., a contract development and manufacturing organization (CDMO) headquartered in Durham and with major operations in Wilmington, has expanded its drug-making capacity by acquiring TriPharm Services.

Burlington-based LabCorp has introduced a suite of cell and gene therapy development services from Covance, its drug development business, to help biopharmaceutical companies develop cell and gene therapies for cancer and other diseases.

Q2 Solutions, a Morrisville clinical trial laboratory services provider, announced plans today for a new $73 million precision medicine facility in Durham that is expected to create 749 jobs over seven years.

Raybow Pharmaceutical acquires PhamAgra Labs, a custom R&D company in Brevard, and plans to triple the number of employees in the next several years.

TriPharm Services, a new Morrisville-based contract pharmaceutical development and manufacturing organization, is commissioning a new specialized manufacturing operation using the latest isolator manufacturing equipment.

The brainchild of a Duke University medical student was transformed, over time, into one of the world’s leading life sciences companies. Now Burlington-based LabCorp is celebrating its 50th anniversary as a global life science leader.

Two North Carolina life science companies have teamed up to resolve a multi-year, national shortage of an important drug.

The U.S. Department of Health and Human Services has exercised its option to purchase an additional 10,000 doses of BioCryst Pharmaceutical’s approved antiviral influenza therapy, RAPIVAV.

Accelerated Enrollment Solutions, a business unit of Wilmington’s Pharmaceutical Product Development, has purchased the clinical research site business of clinical trial development company Bioclinica.

Durham contract services organization KBI Biopharma is working with two other companies to develop a novel therapy to treat inflammatory diseases.

GLAS, a Winston-Salem company that provides human biospecimens and consulting services to medical researchers, has been acquired by Precision for Medicine of Bethesda, Md.

Metabolon, a Morrisville precision health company specializing in a technology called metabolomics, is teaming with three Canadian research groups to study biomarkers and reduce frailty in old age.